Intravascular ULTRA sound-guided percutaneous coronary intervention in patients with STEMI: Rationale and design of the ULTRA-STEMI trial

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Cardiol. Apr 26, 2025; 17(4): 106072
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.106072

Full Size Figure Download Figure

Figure 3 Anticipated timeline of the ULTRA-STEMI trial.

Citation: Karagiannidis E, Papazoglou AS, Samaras A, Nasoufidou A, Zormpas G, Tagarakis G, Theodoropoulos KC, Papadakis M, Tzikas A, Fragakis N, Kassimis G. Intravascular ULTRA sound-guided percutaneous coronary intervention in patients with STEMI: Rationale and design of the ULTRA-STEMI trial. World J Cardiol 2025; 17(4): 106072
URL: https://www.wjgnet.com/1949-8462/full/v17/i4/106072.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i4.106072

Karagiannidis E, Papazoglou AS, Samaras A, Nasoufidou A, Zormpas G, Tagarakis G, Theodoropoulos KC, Papadakis M, Tzikas A, Fragakis N, Kassimis G. Intravascular ULTRA sound-guided percutaneous coronary intervention in patients with STEMI: Rationale and design of the ULTRA-STEMI trial. World J Cardiol 2025; 17(4): 106072 [PMID: 40308625 DOI: 10.4330/wjc.v17.i4.106072]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.